Company profile: Bioscript
1.1 - Company Overview
Company description
- Provider of regulatory consulting, product lifecycle support, and strategic medical communications services. Offerings include medical communications, market access consulting, regulatory writing, Bioscript Data Insights with tools like KOLNavigator, PubsNavigator and EventsNavigator, plus rare disease and oncology consulting covering strategy, engagement, communications, market access and regulatory writing.
Products and services
- Regulatory Writing: Module-based service that engineers protocols, CSRs, patient narratives, CTD submission modules, regulatory responses, and medical device documentation for comprehensive clinical submissions
- Market Access Consulting: Evidence-led practice that architects market access strategy, delivers pricing and reimbursement, orchestrates payer-engagement, and crafts value communication
- Medical Communications: Digital-enabled offering that architects communication strategies, coordinates expert engagement, runs educational meetings, produces internal/external training, drives digital engagement, and manages publication planning
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bioscript
Amerilab Technologies
HQ: United States
Website
- Description: Provider of effervescent product manufacturing and development, producing effervescent tablets for dietary supplements, nutraceuticals, herbals and pharmaceuticals; effervescent and non-effervescent powders in sachets or sticks; packaging and pouching (tubed and foil wrapping, sachet/stick); R&D from concept to commercialization; and custom formulation, blending, tableting and packaging services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amerilab Technologies company profile →
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
Concept Life Sciences
HQ: United Kingdom
Website
- Description: Provider of scientific laboratory and consulting services, offering integrated drug discovery and development; molecular biology (gene expression analysis, transcriptomics, genetic modification); protein production; spatial and structural biology; ADME & DMPK assays; and analytical testing and environmental consulting for pharmaceutical, biotechnology, agrochemical, and environmental sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Concept Life Sciences company profile →
Sofar Farmaceutici
HQ: United States
Website
- Description: Provider of dietary supplements and medical devices, including Sofargen, a silver sulfadiazine topical dressing launched in 1985 and listed by WHO among its 200 essential drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sofar Farmaceutici company profile →
PHMR
HQ: United Kingdom
Website
- Description: Provider of strategic consulting services to biopharmaceutical, diagnostics, MedTech, and life science companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PHMR company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bioscript
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bioscript
2.2 - Growth funds investing in similar companies to Bioscript
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bioscript
4.2 - Public trading comparable groups for Bioscript
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →